Single-cell genotyping of MDS/CMML clonal output, VTE risk in diffuse glioma, and Del(1p32) is an adverse prognostic factor in myeloma
Blood Podcast
00:00
Introduction
Learn more about the risk of venous thromboembolism in patients with adult-type diffuse glioma. discuss the importance of one P32 deletions as an independent and adverse prognostic factor in myeloma. Discuss how azocytidine therapy influences the contributions of mutated HSC clones to hematopoiesis in MDS and CMML.
Transcript
Play full episode
